bioRxivBioinformaticsPreprint
DeepPhage: leveraging the power of NGS phage display data, an in-depth analysis for the identification of Eu3+-binding peptides
Christoph BloßiD, Amelie Hübner, Clément Renard, Gerda TechertiD, Franziska LedereriD
Abstract
Summary: Phage Surface Display (PSD) is a widely used molecular technique for identifying peptides and antibodies with applications in therapeutics, diagnostics, and materials science. The use of highly diverse phage libraries enables the screening of millions of ligand variants, while the integration of Next-Generation Sequencing (NGS) provides high-throughput access to the sequence composition of selected phage populations. Despite these advances, the identification of genuine target-binding ligands remains challenging due to biases introduced during library construction, biological selection and propagation, as well as the enrichment of target-unrelated peptides (TUPs). These factors distort sequence distributions and complicate the interpretation of PSD-NGS experiments, particularly when comparing multiple libraries or selection rounds. Consequently, robust computational methods are required to distinguish biologically relevant enrichments from technical artifacts. We demonstrate DeepPhage using PSD-NGS datasets from Eu3+ biopanning experiments, in which differences in peptide composition between experimental conditions were identified and a systematic comparison of several conditions was made possible. It was developed to address the lack of comparative analysis tools for large-scale PSD-NGS experiments by combining statistical analyses with comprehensive visualisation. These features form the basis for a more reliable interpretation of phage display selection experiments. DeepPhage provides a reproducible framework for comparative PSD-NGS analysis, which supports the identification of sequence bias, library heterogeneity and potential target-binding peptides across multiple experiments. The software is freely available as an open-source command-line application, so that it can be deployed on a high computer cluster for particularly large volumes of data. Availability and implementation: DeepPhage is entirely open source and is available on GitLab https://codebase.helmholtz.cloud/phagelabs-hif/DeepPhage/-/tree/stable_release_v0.1 under the GPL v3 licence. The repository contains documentation, installation instructions, a user guide and example data. The sample data used for the demonstration is available at the online repository RODARE (https://doi.org/10.14278/rodare.4647).
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: benchmarking
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- P3ANUT: An enhanced DNA sequencing analysis platform for uncovering and correcting errors in peptide phage display library screening
Liam Tucker, Ethan Koland, … Chris J Morris·bioRxiv·May 12, 2025
- In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues
Kārlis Pleiko, Kristina Põšnograjeva, … Tambet Teesalu·Nucleic Acids ResearchPeer-reviewed·Jan 6, 2021
- Reproducible Discovery of Cell-Binding Peptides "Lost" in Bulk Amplification via Emulsion Amplification in Phage Display Panning
W. L. Matochko, F. Deiss, … R. Derda·bioRxiv·Oct 31, 2021
- Pitfalls in understanding PhIP-Seq data: technical variability, replicability, and best practices for interpretation
Lovro Trgovec-Greif, Thomas J. Vogl·bioRxiv·Sep 21, 2026
- Defining short linear motif binding determinants by phage-based multiplexed deep mutational scanning
Caroline Benz, Lars Maassen, … Ylva Ivarsson·Protein SciencePeer-reviewed·May 24, 2025
- PhageTerm: a Fast and User-friendly Software to Determine Bacteriophage Termini and Packaging Mode using randomly fragmented NGS data
J. R. Garneau, F. Depardieu, … M. Monot·bioRxiv·Feb 16, 2017